Iovanace Biotherapeutics (IOVA) PT Lowered to $35 at Piper Sandler
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Price: $4.28 -3.6%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 31
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 31
Join SI Premium – FREE
Piper Sandler analyst Joseph Catanzaro lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $35.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) PT Lowered to JPY6,500 at JPMorgan
- JPMorgan Upgrades Japan Post Insurance Co., Ltd (7181:JP) (JPPIF) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
